Plain-English translation of NCT06846320 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it helps treat generalized anxiety disorder when added to antidepressants that you're already taking. Some people don't get enough relief from antidepressants alone, and researchers want to know if this new medication can help those people feel better. You would take the medication (or a placebo) by mouth for 6 weeks while staying on your current antidepressant.
Many people with generalized anxiety disorder don't feel well enough even when taking antidepressants at the right dose for long enough. This trial exists to find out whether this new treatment could help fill that gap and give people better relief from their anxiety symptoms.
You likely qualify if…
You likely don't qualify if…
You would visit a clinic or hospital regularly over 10 weeks total — 6 weeks taking the study medication (or placebo) plus your antidepressant, then 4 weeks of follow-up. At each visit, the research team would check how you're doing through conversations, questionnaires, blood tests, and assessments of any side effects. You would take oral capsules at home as instructed, in addition to your regular antidepressant medication.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
United States